Outcome After Avascular Necrosis of the Femoral Head in Young Patients
NCT ID: NCT03753282
Last Updated: 2019-03-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2019-01-30
2019-03-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
2. The short and long term outcomes of AVN patients undergoing THA with respect to complications, reoperations and quality of life are investigated. Potential risk factors for adverse outcomes will be investigated.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Talar Avascular Necrosis: Surgical Angiogenesis vs. Core Decompression
NCT02289976
Autologous Bone Marrow Concentration for Avascular Necrosis of Femoral Head
NCT03787329
Talar Avascular Necrosis: Surgical Angiogenesis vs. Core Decompression
NCT02291900
Factors Influencing the Risk of Surgical Site Infections and Wound Complications in Operatively Treated Ankle Fractures in the Elderly
NCT04379791
Decompression Coring Versus Conservative Therapy in Patients With Avascular Necrosis of the Hip Related to Sickle Cell Disease
NCT00006130
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The impact of THA after AVN on activities of daily living will be assessed by Euroquol 5 Dimensions (EQ-5D-5L) and Hip disability and Osteoarthritis Outcome Score (HOOS) questionnaires.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Population 1
Patients with a first AVN-related contact (initial or confirmed diagnosis) at the Universitätsspital Basel (USB) or Kantonsspital Basel-Liestal (KSBL) in the years between 1999-2006 (being assessed by questionnaires for patient reported outcome and questionnaire for course of the disease)
questionnaires for patient reported outcome
questionnaires with respect to outcomes:
* Reoperations
* Short term complications
* Long term complications
* EQ-5D (current)
* HOOS (current)
* disease related change of occupation
* use of walking aids
* comorbidities
* medication
questionnaire for course of the disease
questionnaires to assess course of the disease:
* from initial diagnosis of AVN to joint replacement as total hip arthroplasty (THA)
* therapeutic interventions
Population 2
Patients with a THA because of AVN in the years 2000-2007 (being assessed by questionnaires for patient reported outcome and questionnaire for course of the disease)
questionnaires for patient reported outcome
questionnaires with respect to outcomes:
* Reoperations
* Short term complications
* Long term complications
* EQ-5D (current)
* HOOS (current)
* disease related change of occupation
* use of walking aids
* comorbidities
* medication
questionnaire for course of the disease
questionnaires to assess course of the disease:
* from initial diagnosis of AVN to joint replacement as total hip arthroplasty (THA)
* therapeutic interventions
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
questionnaires for patient reported outcome
questionnaires with respect to outcomes:
* Reoperations
* Short term complications
* Long term complications
* EQ-5D (current)
* HOOS (current)
* disease related change of occupation
* use of walking aids
* comorbidities
* medication
questionnaire for course of the disease
questionnaires to assess course of the disease:
* from initial diagnosis of AVN to joint replacement as total hip arthroplasty (THA)
* therapeutic interventions
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Informed Consent
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Basel, Switzerland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Franziska Saxer, Dr. med
Role: PRINCIPAL_INVESTIGATOR
Dep. of Orthopedic and Trauma Surgery; University Hospital Basel
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-01264; ch18Saxer3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.